市場調査レポート

商品コード

1701737

インターベンショナル腫瘍学の市場規模、シェア、成長分析、製品タイプ別、処置の種類別、がんの種類別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Interventional Oncology Market Size, Share, and Growth Analysis, By Product Type (Ablation Devices, Embolization Devices), By Procedure Type (Thermal Ablation, Non-thermal Ablation), By Cancer Type, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月07日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

インターベンショナル腫瘍学の世界市場規模は、2023年に27億5,000万米ドルと評価され、2024年の30億米ドルから2032年には60億2,000万米ドルに成長し、予測期間中（2025年～2032年）のCAGRは9.1％で成長する見通しです。

インターベンショナル腫瘍学は、がんの診断と治療に低侵襲技術とCT、超音波、MRI、X線などの高度な画像誘導技術を活用する、がん治療における新興の急成長分野です。この革新的なアプローチは、生検針、アブレーション電極、血管内カテーテルなどの特殊な器具を用いて、到達困難な部位であっても腫瘍を正確に標的にすることを可能にします。インターベンショナル腫瘍学は、手術や放射線といった従来の治療と並ぶ重要な要素として、がんの症状を緩和しながら侵襲的な処置の必要性を減らすことを目的とした集中的な治療を提供します。さらに、インターベンショナル腫瘍学者は、内視鏡検査や大腸内視鏡検査の実施に長けており、肝臓、腎臓、肺、乳房、前立腺、転移性腫瘍など様々ながんに対応し、最終的には患者の転帰を改善します。

市場概要
アブレーションデバイス
- 高周波（RF）アブレーション装置
- マイクロ波アブレーション装置
- 凍結アブレーション装置
- 不可逆的電気穿孔装置
- 高強度焦点式超音波（HIFU）システム
塞栓デバイス
- 放射線塞栓術デバイス（Y-90マイクロスフェア）
- 動脈塞栓化学療法（TACE）薬剤
- 薬剤溶出ビーズ（DEB）
- 非薬剤溶出ビーズ
サポートデバイス
- マイクロカテーテル
- ガイドワイヤー
- 針（生検、アブレーション）
- 導入シースとシース
- 画像造影剤
その他
- ロボット支援システム
- 計画とナビゲーションのためのソフトウェアプラットフォーム

インターベンショナル腫瘍学市場規模：処置の種類別& CAGR（2025-2032）

市場概要
熱アブレーション
非熱アブレーション
塞栓術
椎体形成術とセメント形成術
生検および腫瘍マーキング手順

インターベンショナル腫瘍学市場規模：がんの種類別& CAGR（2025-2032）

市場概要
肝臓がん
肺がん
腎臓がん
骨転移
乳がん
前立腺がん
膵臓がん
大腸がん
その他

インターベンショナル腫瘍学市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
病院
外来手術センター（ASC）
がん研究センター
インターベンショナルラジオロジークリニック

インターベンショナル腫瘍学市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Boston Scientific Corporation-USA
Medtronic plc-Ireland
Siemens Healthineers-Germany
Terumo Corporation-Japan
Becton, Dickinson and Company（BD）-USA
Merit Medical Systems-USA
AngioDynamics, Inc.-USA
ALPINION MEDICAL SYSTEMS-South Korea
ATRICURE, INC.-USA
EndoShape, Inc.-USA
ABK Biomedical Inc.-Canada
Cook Medical Inc.-USA
Sirtex Medical Limited-Australia
BTG International Ltd.-UK
Hologic, Inc.-USA
Canon Medical Systems Corporation-Japan
GE Healthcare-USA
Philips Healthcare-Netherlands

結論と提言

Product Code: SQMIG35G2238

Global Interventional Oncology Market size was valued at USD 2.75 billion in 2023 and is poised to grow from USD 3.0 billion in 2024 to USD 6.02 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

Interventional oncology is an emerging and rapidly growing field in cancer care, leveraging minimally invasive techniques and advanced image guidance technologies, such as CT, ultrasound, MRI, and X-rays, to diagnose and treat cancer. This innovative approach allows for precise targeting of tumors, even in difficult-to-reach areas, using specialized instruments like biopsy needles, ablation electrodes, and intravascular catheters. As a key component alongside traditional therapies such as surgery and radiation, interventional oncology provides focused treatments that aim to reduce the need for invasive procedures while alleviating cancer symptoms. Additionally, interventional oncologists are skilled in conducting endoscopies and colonoscopies, addressing various cancers, including liver, kidney, lung, breast, prostate, and metastatic tumors, ultimately improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising global incidence of cancer serves as a major catalyst for the interventional oncology market. As the population ages and lifestyle-related risk factors contribute to higher cancer rates, there is an increasing need for effective treatments. This growing demand encourages healthcare providers to implement cutting-edge interventional techniques that not only improve patient outcomes but also enhance survival rates. Consequently, the market is witnessing significant innovation and expansion driven by the urgent requirement for advanced cancer care solutions tailored to meet the needs of patients worldwide. This momentum is likely to continue as the challenge of cancer persists.

Restraints in the Global Interventional Oncology Market

A significant challenge facing the Global Interventional Oncology market is the limited awareness and training regarding interventional oncology techniques among healthcare professionals. Many practitioners lack familiarity with the newest innovations and procedures, which can result in their underutilization. This gap in knowledge can hinder the market's growth potential. Furthermore, the necessity for specialized training may impede the swift adoption of advanced technologies across different healthcare environments. As healthcare providers navigate these challenges, the overall progress in integrating interventional oncology practices may be delayed, ultimately affecting the market's expansion and evolution in an increasingly competitive landscape.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a profound shift towards minimally invasive techniques, propelled by the dual benefits of reduced recovery times and minimized complications for patients. This trend is gaining traction as both patients and healthcare professionals increasingly prefer these innovative methods, which are designed to improve treatment outcomes. Furthermore, advancements in technology, such as enhanced imaging modalities and precision-guided interventions, are being rapidly integrated into clinical practice, thus elevating the efficacy and safety of oncological procedures. This evolution not only reflects a broader movement towards patient-centered care but also positions minimally invasive interventional oncology as a key growth driver in the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2025-2032)

Market Overview
Ablation Devices
- Radiofrequency (RF) Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Irreversible Electroporation Devices
- High-Intensity Focused Ultrasound (HIFU) Systems
Embolization Devices
- Radioembolization Devices (Y-90 Microspheres)
- Transarterial Chemoembolization (TACE) Agents
- Drug-Eluting Beads (DEBs)
- Non-drug-eluting Beads
Support Devices
- Microcatheters
- Guidewires
- Needles (biopsy, ablation)
- Introducers and Sheaths
- Imaging Contrast Agents
Others
- Robotic Assistance Systems
- Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2025-2032)

Market Overview
Thermal Ablation
Non-thermal Ablation
Embolization Procedures
Vertebroplasty & Cementoplasty
Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2025-2032)

Market Overview
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastases
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Colorectal Cancer
Others

Global Interventional Oncology Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers (ASCs)
Cancer Research Centers
Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2025-2032)

North America (Product Type, Procedure Type, Cancer Type, End User)
- US
- Canada
Europe (Product Type, Procedure Type, Cancer Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure Type, Cancer Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Boston Scientific Corporation - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALPINION MEDICAL SYSTEMS - South Korea
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATRICURE, INC. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EndoShape, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABK Biomedical Inc. - Canada
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sirtex Medical Limited - Australia
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTG International Ltd. - UK
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare - Netherlands
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments